
Fidecon Pharma Private Limited
About Fidecon Pharma Private Limited
Data last updated:
Fidecon Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U35105RJ2015PTC047428. Its GSTIN is 08AACCF5765C1ZP (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjeev Kumar Mittal and Sanchit Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 10 Ganga Sagar Colony Vaishali Nagar, Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.17 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹4,810 (net margin -1.5%) and EBITDA of -₹11,082 (EBITDA margin -3.5%). Revenue has declined at a compounded annual rate (CAGR) of 49% over three years and 38% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Fidecon Pharma has one previous CIN (Corporate Identification Number): U24232RJ2015PTC047428. The current CIN is U35105RJ2015PTC047428, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U35105RJ2015PTC047428 | Current |
| U24232RJ2015PTC047428 | Previous |
Contact details
Fidecon Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 10 Ganga Sagar Colony Vaishali Nagar, Jaipur, Rajasthan, India – 302021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fidecon Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fidecon Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fidecon Pharma Private Limited, buy the company report.
Financials of Fidecon Pharma Private Limited
FY 2025 filings availableFidecon Pharma Private Limited reported revenue of ₹3.17 Lakh (up 27% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 27% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 38%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.17 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11,082 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,810 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.5% | ||||
| Net Profit Margin | -1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fidecon Pharma Private Limited, buy the company report.
Board of directors of Fidecon Pharma Private Limited
Fidecon Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Kumar Mittal | Director | 25 Apr 2015 | 11 Years 6 Months | Current |
| Sanchit Mittal Also directs: Palanhaar Timber Paper Limited Liability Partnership | Additional Director | 16 Aug 2021 | 5 Years 3 Months | Current |
Auditor
Fidecon Pharma Private Limited is audited by RAM NARESH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAM NARESH & CO | FY 2023 | 014379C |
Shareholding
The shareholding of Fidecon Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fidecon Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fidecon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fidecon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fidecon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCF5765C1ZP | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fidecon Pharma Private Limited, buy the company report.
Recent activity
Fidecon Pharma Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Kamal Kant Garg ceased to be Director on 16 Aug 2021.
Frequently asked questions
Fidecon Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2015 (11+ years old) and is registered under CIN U35105RJ2015PTC047428.
Fidecon Pharma has 2 current directors:
- Sanjeev Kumar Mittal - Director
- Sanchit Mittal - Additional Director
The latest financial statements of Fidecon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Fidecon Pharma is 08AACCF5765C1ZP, registered in Rajasthan.
The CIN (Corporate Identification Number) of Fidecon Pharma is U35105RJ2015PTC047428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fidecon Pharma was incorporated on 25 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.
Kamal Kant Garg ceased to be Director on 16 Aug 2021. Sanchit Mittal was appointed as Additional Director on 16 Aug 2021. Sanjeev Kumar Mittal was appointed as Director on 25 Apr 2015.
The registered office of Fidecon Pharma is at C – 10 Ganga Sagar Colony Vaishali Nagar, Jaipur, Rajasthan, India – 302021.
Fidecon Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Fidecon Pharma is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.

